Bleakley Financial Group LLC lifted its position in shares of Nutrien Ltd. (NYSE:NTR – Free Report) by 38.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 49,328 shares of the company’s stock after buying an additional 13,586 shares during the quarter. Bleakley Financial Group LLC’s holdings in Nutrien were worth $2,896,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Root Financial Partners LLC acquired a new stake in Nutrien in the 3rd quarter worth about $37,000. Huntington National Bank increased its holdings in shares of Nutrien by 72.6% during the second quarter. Huntington National Bank now owns 656 shares of the company’s stock worth $38,000 after purchasing an additional 276 shares during the period. Geneos Wealth Management Inc. raised its position in shares of Nutrien by 42.4% in the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock valued at $43,000 after buying an additional 219 shares in the last quarter. Bessemer Group Inc. boosted its stake in shares of Nutrien by 27.7% in the third quarter. Bessemer Group Inc. now owns 937 shares of the company’s stock valued at $55,000 after buying an additional 203 shares during the period. Finally, AlphaCore Capital LLC acquired a new stake in Nutrien during the second quarter worth approximately $56,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Stock Up 1.0%
Shares of NYSE NTR opened at $71.89 on Tuesday. The company has a market cap of $34.61 billion, a price-to-earnings ratio of 15.43 and a beta of 0.73. The company has a current ratio of 1.34, a quick ratio of 0.70 and a debt-to-equity ratio of 0.37. Nutrien Ltd. has a 12 month low of $45.78 and a 12 month high of $73.55. The stock has a 50-day moving average price of $66.43 and a two-hundred day moving average price of $60.80.
Nutrien Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.55 per share. This is a positive change from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.20 annualized dividend and a dividend yield of 3.1%. Nutrien’s dividend payout ratio (DPR) is 46.78%.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the company. UBS Group lifted their price objective on Nutrien from $58.00 to $63.00 and gave the company a “neutral” rating in a report on Monday, January 12th. Barclays boosted their price target on Nutrien from $64.00 to $70.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutrien in a research report on Monday, December 29th. Morgan Stanley raised shares of Nutrien from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $70.00 to $77.00 in a report on Wednesday, January 14th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Nutrien from $68.00 to $78.00 and gave the company an “overweight” rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $71.17.
Get Our Latest Stock Report on Nutrien
Nutrien News Roundup
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Several firms raised price targets on NTR (new targets include $85, $78, $77 and $74), signaling upward revisions to analyst outlooks that can support buying interest. Price Target $85 Price Target $78 Price Target $77 Price Target $74
- Positive Sentiment: Analysis highlights attractive valuation after Nutrien’s strong results, dividend increase and ongoing buybacks — factors that support shareholder returns and can justify a higher multiple. Valuation & Dividend/Buybacks
- Neutral Sentiment: A Zacks piece examines whether value investors should buy NTR, focusing on earnings-estimate trends and the Zacks Rank methodology — useful context but not an immediate catalyst. Zacks Analysis
- Negative Sentiment: BNP Paribas Exane downgraded Nutrien from “outperform” to “neutral,” citing rising pressure on nitrogen prices — a direct earnings risk for Nutrien’s fertilizer segment and a likely headwind for the stock. BNP Paribas Downgrade
- Negative Sentiment: Market summaries (e.g., Finviz) echoed the downgrade note, increasing visibility of the bearish analyst stance and potentially amplifying short-term selling pressure. Finviz Summary
Nutrien Profile
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Recommended Stories
- Five stocks we like better than Nutrien
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
